A tale of two sites: How inflammation can reshape the microbiomes of the gut and lungs

Journal of Leukocyte Biology

Volumn 100, Issue 5, 2016, Pages 943-950

  Scales, Brittan S ^a   Dickson, Robert P ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cystic fibrosis; E. coli; Inflammatory bowel disease; Nitrate reduction; P. aeruginosa

Indexed keywords

NITRATE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROGEN;

ANAEROBIC METABOLISM; ASTHMA; BACTERIAL COLONIZATION; BACTERIAL GROWTH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DIGESTIVE SYSTEM INFLAMMATION; ESCHERICHIA COLI; FEEDBACK SYSTEM; GAMMAPROTEOBACTERIA; GASTROINTESTINAL MUCOSA; HUMAN; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFLAMMATION; REVIEW; ANAEROBIC GROWTH; COLITIS; ESCHERICHIA COLI INFECTION; GASTROINTESTINAL TRACT; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; MICROBIOLOGY; MICROFLORA; MUCUS; OXIDATION REDUCTION REACTION; PHYSIOLOGICAL FEEDBACK; PHYSIOLOGY; PSEUDOMONAS INFECTION;

ANAEROBIOSIS; COLITIS; CYSTIC FIBROSIS; ESCHERICHIA COLI INFECTIONS; FEEDBACK, PHYSIOLOGICAL; GAMMAPROTEOBACTERIA; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; LUNG; MICROBIOTA; MUCUS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITROGEN; OXIDATION-REDUCTION; PSEUDOMONAS INFECTIONS;

EID: 84994101000     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3MR0316-106R     Document Type: Review

References (80)

1. Dickson, R. P., Huffnagle, G. B. (2015) The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog. 11, e1004923.
2. Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., Huffnagle, G. B. (2016) The microbiome and the respiratory tract. Annu. Rev. Physiol. 78, 481-504.
3. Winter, S. E., Bäumler, A. J. (2014) Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes 5, 71-73.
4. Dalal, S. R., Chang, E. B. (2014) The microbial basis of inflammatory bowel diseases. J. Clin. Invest. 124, 4190-4196.
5. Donaldson, G. P., Lee, S. M., Mazmanian, S. K. (2016) Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 14, 20-32.
6. Keeney, K. M., Yurist-Doutsch, S., Arrieta, M. C., Finlay, B. B. (2014) Effects of antibiotics on human microbiota and subsequent disease. Annu. Rev. Microbiol. 68, 217-235.
7. Lopez, C. A., Rivera-Chávez, F., Byndloss, M. X., Bäumler, A. J. (2015) The periplasmic nitrate reductase NapABC supports luminal growth of Salmonella enterica serovar Typhimurium during colitis. Infect. Immun. 83, 3470-3478.
8. Rivera-Chávez, F., Winter, S. E., Lopez, C. A., Xavier, M. N., Winter, M. G., Nuccio, S. P., Russell, J. M., Laughlin, R. C., Lawhon, S. D., Sterzenbach, T., Bevins, C. L., Tsolis, R. M., Harshey, R., Adams, L. G., Bäumler, A. J. (2013) Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog. 9, e1003267.
9. Bliska, J. B., van der Velden, A. W. (2012) Salmonella “sops” up a preferred electron receptor in the inflamed intestine. MBio 3, e00226-12.
10. Lopez, C. A., Winter, S. E., Rivera-Chávez, F., Xavier, M. N., Poon, V., Nuccio, S. P., Tsolis, R. M., Bäumler, A. J. (2012) Phage-mediated acquisition of a type III secreted effector protein boosts growth of salmonella by nitrate respiration. MBio 3, e00143-12.
11. Vázquez-Torres, A., Bäumler, A. J. (2016) Nitrate, nitrite and nitric oxide reductases: from the last universal common ancestor to modern bacterial pathogens. Curr. Opin. Microbiol. 29, 1-8.
12. Spees, A. M., Wangdi, T., Lopez, C. A., Kingsbury, D. D., Xavier, M. N., Winter, S. E., Tsolis, R. M., Bäumler, A. J. (2013) Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. MBio 4, e0043-13.
13. Winter, S. E., Winter, M. G., Xavier, M. N., Thiennimitr, P., Poon, V., Keestra, A. M., Laughlin, R. C., Gomez, G., Wu, J., Lawhon, S. D., Popova, I. E., Parikh, S. J., Adams, L. G., Tsolis, R. M., Stewart, V. J., Bäumler, A. J. (2013) Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711.
14. Lupp, C., Robertson, M. L., Wickham, M. E., Sekirov, I., Champion, O. L., Gaynor, E. C., Finlay, B. B. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 204.
15. Stecher, B., Robbiani, R., Walker, A. W., Westendorf, A. M., Barthel, M., Kremer, M., Chaffron, S., Macpherson, A. J., Buer, J., Parkhill, J., Dougan, G., von Mering, C., Hardt, W. D. (2007) Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5, 2177-2189.
16. Raetz, M., Hwang, S. H., Wilhelm, C. L., Kirkland, D., Benson, A., Sturge, C. R., Mirpuri, J., Vaishnava, S., Hou, B., Defranco, A. L., Gilpin, C. J., Hooper, L. V., Yarovinsky, F. (2013) Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-g-dependent elimination of Paneth cells. Nat. Immunol. 14, 136-142.
17. Molloy, M. J., Grainger, J. R., Bouladoux, N., Hand, T. W., Koo, L. Y., Naik, S., Quinones, M., Dzutsev, A. K., Gao, J. L., Trinchieri, G., Murphy, P. M., Belkaid, Y. (2013) Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis. Cell Host Microbe 14, 318-328.
18. Lau, H. Y., Huffnagle, G. B., Moore, T. A. (2008) Host and microbiota factors that control Klebsiella pneumoniae mucosal colonization in mice. Microbes Infect. 10, 1283-1290.
19. Krogius-Kurikka, L., Lyra, A., Malinen, E., Aarnikunnas, J., Tuimala, J., Paulin, L., Mäkivuokko, H., Kajander, K., Palva, A. (2009) Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 9, 95.
20. Kerckhoffs, A. P., Ben-Amor, K., Samsom, M., van der Rest, M. E., de Vogel, J., Knol, J., Akkermans, L. M. (2011) Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J. Med. Microbiol. 60, 236-245.
21. Carroll, I. M., Ringel-Kulka, T., Siddle, J. P., Ringel, Y. (2012) Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24, 521-530, e248.
22. Gophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. F., Veldhuyzen van Zanten, S. J. (2006) Differences between tissue-associated intestinal microfloras of patients with Crohn’s disease and ulcerative colitis. J. Clin. Microbiol. 44, 4136-4141.
23. Baumgart, M., Dogan, B., Rishniw, M., Weitzman, G., Bosworth, B., Yantiss, R., Orsi, R. H., Wiedmann, M., McDonough, P., Kim, S. G., Berg, D., Schukken, Y., Scherl, E., Simpson, K. W. (2007) Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. ISME J. 1, 403-418.
24. Seksik, P., Rigottier-Gois, L., Gramet, G., Sutren, M., Pochart, P., Marteau, P., Jian, R., Doré, J. (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn’s disease of the colon. Gut 52, 237-242.
25. Winter, S. E., Bäumler, A. J. (2014) Why related bacterial species bloom simultaneously in the gut: principles underlying the ‘Like will to like’ concept. Cell. Microbiol. 16, 179-184.
26. Ródenas, J., Mitjavila, M. T., Carbonell, T. (1995) Simultaneous generation of nitric oxide and superoxide by inflammatory cells in rats. Free Radic. Biol. Med. 18, 869-875.
27. Hassett, D. J., Cuppoletti, J., Trapnell, B., Lymar, S. V., Rowe, J. J., Yoon, S. S., Hilliard, G. M., Parvatiyar, K., Kamani, M. C., Wozniak, D. J., Hwang, S. H., McDermott, T. R., Ochsner, U. A. (2002) Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv. Drug Deliv. Rev. 54, 1425-1443.
28. Saito, S., Onozuka, K., Shinomiya, H., Nakano, M. (1991) Sensitivity of bacteria to NaNO2 and to L-arginine-dependent system in murine macrophages. Microbiol. Immunol. 35, 325-329.
29. Major, T. A., Panmanee, W., Mortensen, J. E., Gray, L. D., Hoglen, N., Hassett, D. J. (2010) Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob. Agents Chemother. 54, 4671-4677.
30. Privett, B. J., Deupree, S. M., Backlund, C. J., Rao, K. S., Johnson, C. B., Coneski, P. N., Schoenfisch, M. H. (2010) Synergy of nitric oxide and silver sulfadiazine against gram-negative, gram-positive, and antibioticresistant pathogens. Mol. Pharm. 7, 2289-2296.
31. Reighard, K. P., Schoenfisch, M. H. (2015) Antibacterial action of nitric oxide-releasing chitosan oligosaccharides against Pseudomonas aeruginosa under aerobic and anaerobic conditions. Antimicrob. Agents Chemother. 59, 6506-6513.
32. Ajiboye, T. O., Naibi, A. M., Abdulazeez, I. O., Alege, I. O., Mohammed, A. O., Bello, S. A., Yusuf, I. I., Ibitoye, O. B., Muritala, H. F. (2016) Involvement of oxidative stress in bactericidal activity of 2-(2-nitrovinyl) furan against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Microb. Pathog. 91, 107-114.
33. Lee, R. J., Cohen, N. A. (2014) Bitter and sweet taste receptors in the respiratory epithelium in health and disease. J. Mol. Med. 92, 1235-1244.
34. Bogdan, C. (2015) Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 36, 161-178.
35. Fang, F. C. (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2, 820-832.
36. Karupiah, G., Hunt, N. H., King, N. J., Chaudhri, G. (2000) NADPH oxidase, Nramp1 and nitric oxide synthase 2 in the host antimicrobial response. Rev. Immunogenet. 2, 387-415.
37. Hickman-Davis, J. M., Fang, F. C., Nathan, C., Shepherd, V. L., Voelker, D. R., Wright, J. R. (2001) Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L517-L523.
38. Tiso, M., Schechter, A. N. (2015) Nitrate reduction to nitrite, nitric oxide and ammonia by gut bacteria under physiological conditions. PLoS One 10, e0119712.
39. Lyczak, J. B., Cannon, C. L., Pier, G. B. (2002) Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15, 194-222.
40. Harrison, F. (2007) Microbial ecology of the cystic fibrosis lung. Microbiology 153, 917-923.
41. Ratjen, F., Döring, G. (2003) Cystic fibrosis. Lancet 361, 681-689.
42. Boucher, R. C. (2007) Evidence for airway surface dehydration as the initiating event in CF airway disease. J. Intern. Med. 261, 5-16.
43. Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaoz, U., Andersen, G. L., Brown, R., Fujimura, K. E., Wu, B., Tran, D., Koff, J., Kleinhenz, M. E., Nielson, D., Brodie, E. L., Lynch, S. V. (2010) Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 5, e11044.
44. Hoiby, N., Frederiksen, B., Pressler, T. (2005) Eradication of early Pseudomonas aeruginosa infection. J. Cyst. Fibrosis 4(Suppl 2), 49-54.
45. Sabra, W., Kim, E. J., Zeng, A. P. (2002) Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures. Microbiology 148, 3195-3202.
46. Arai, H. (2011) Regulation and function of versatile aerobic and anaerobic respiratory metabolism in Pseudomonas aeruginosa. Front. Microbiol. 2, 103.
47. Steen, A., Utkür, F. O., Borrero-de Acuña, J. M., Bunk, B., Roselius, L., Bühler, B., Jahn, D., Schobert, M. (2013) Construction and characterization of nitrate and nitrite respiring Pseudomonas putida KT2440 strains for anoxic biotechnical applications. J. Biotechnol. 163, 155-165.
48. Yoon, S. S., Hennigan, R. F., Hilliard, G. M., Ochsner, U. A., Parvatiyar, K., Kamani, M. C., Allen, H. L., DeKievit, T. R., Gardner, P. R., Schwab, U., Rowe, J. J., Iglewski, B. H., McDermott, T. R., Mason, R. P., Wozniak, D. J., Hancock, R. E., Parsek, M. R., Noah, T. L., Boucher, R. C., Hassett, D. J. (2002) Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3, 593-603.
49. Van Alst, N. E., Picardo, K. F., Iglewski, B. H., Haidaris, C. G. (2007) Nitrate sensing and metabolism modulate motility, biofilm formation, and virulence in Pseudomonas aeruginosa. Infect. Immun. 75, 3780-3790.
50. Bjarnsholt, T., Jensen, P. O., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., Høiby, N. (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44, 547-558.
51. Kolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., Ciofu, O., Mandsberg, L., Kharazmi, A., Döring, G., Givskov, M., Høiby, N., Jensen, P. O. (2010) Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 65, 57-62.
52. Kolpen, M., Bjarnsholt, T., Moser, C., Hansen, C. R., Rickelt, L. F., Kühl, M., Hempel, C., Pressler, T., Høiby, N., Jensen, P. O. (2014) Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen. Clin. Exp. Immunol. 177, 310-319.
53. Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., Botzenhart, K., Yankaskas, J. R., Randell, S., Boucher, R. C., Döring, G. (2002) Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109, 317-325.
54. Hoboth, C., Hoffmann, R., Eichner, A., Henke, C., Schmoldt, S., Imhof, A., Heesemann, J., Hogardt, M. (2009) Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J. Infect. Dis. 200, 118-130.
55. Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R., Gilpin, D. F., McDowell, A., Elborn, J. S. (2008) Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 177, 995-1001.
56. Khan, T. Z., Wagener, J. S., Bost, T., Martinez, J., Accurso, F. J., Riches, D. W. (1995) Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151, 1075-1082.
57. Balough, K., McCubbin, M., Weinberger, M., Smits, W., Ahrens, R., Fick, R. (1995) The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 20, 63-70.
58. Verhaeghe, C., Delbecque, K., de Leval, L., Oury, C., Bours, V. (2007) Early inflammation in the airways of a cystic fibrosis foetus. J. Cyst. Fibrosis 6, 304-308.
59. Dedon, P. C., Tannenbaum, S. R. (2004) Reactive nitrogen species in the chemical biology of inflammation. Arch. Biochem. Biophys. 423, 12-22.
60. Kolpen, M., Kühl, M., Bjarnsholt, T., Moser, C., Hansen, C. R., Liengaard, L., Kharazmi, A., Pressler, T., Høiby, N., Jensen, P. O. (2014) Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. PLoS One 9, e84353.
61. Jones, K. L., Hegab, A. H., Hillman, B. C., Simpson, K. L., Jinkins, P. A., Grisham, M. B., Owens, M. W., Sato, E., Robbins, R. A. (2000) Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr. Pulmonol. 30, 79-85.
62. Arai, H., Hayashi, M., Kuroi, A., Ishii, M., Igarashi, Y. (2005) Transcriptional regulation of the flavohemoglobin gene for aerobic nitric oxide detoxification by the second nitric oxide-responsive regulator of Pseudomonas aeruginosa. J. Bacteriol. 187, 3960-3968.
63. Linnane, S. J., Keatings, V. M., Costello, C. M., Moynihan, J. B., O’Connor, C. M., Fitzgerald, M. X., McLoughlin, P. (1998) Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am. J. Respir. Crit. Care Med. 158, 207-212.
64. Jöbsis, Q., Raatgeep, H. C., Schellekens, S. L., Kroesbergen, A., Hop, W. C., de Jongste, J. C. (2000) Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur. Respir. J. 16, 95-100.
65. Mhanna, M. J., Ferkol, T., Martin, R. J., Dreshaj, I. A., van Heeckeren, A. M., Kelley, T. J., Haxhiu, M. A. (2001) Nitric oxide deficiency contributes to impairment of airway relaxation in cystic fibrosis mice. Am. J. Respir. Cell Mol. Biol. 24, 621-626.
66. Dickson, R. P., Erb-Downward, J. R., Huffnagle, G. B. (2013) The role of the bacterial microbiome in lung disease. Expert Rev. Respir. Med. 7, 245-257.
67. Huang, Y. J., Boushey, H. A. (2015) The microbiome in asthma. J. Allergy Clin. Immunol. 135, 25-30.
68. Larsen, J. M., Musavian, H. S., Butt, T. M., Ingvorsen, C., Thysen, A. H., Brix, S. (2015) Chronic obstructive pulmonary disease and asthmaassociated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology. Immunology 144, 333-342.
69. Brix, S., Eriksen, C., Larsen, J. M., Bisgaard, H. (2015) Metagenomic heterogeneity explains dual immune effects of endotoxins. J. Allergy Clin. Immunol. 135, 277-280.
70. Larsen, J. M., Steen-Jensen, D. B., Laursen, J. M., Søndergaard, J. N., Musavian, H. S., Butt, T. M., Brix, S. (2012) Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One 7, e31976.
71. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
72. Hartmann, G., Krieg, A. M. (2000) Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164, 944-953.
73. Rankin, R., Pontarollo, R., Ioannou, X., Krieg, A. M., Hecker, R., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2001) CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11, 333-340.
74. Kant, R., de Vos, W. M., Palva, A., Satokari, R. (2014) Immunostimulatory CpG motifs in the genomes of gut bacteria and their role in human health and disease. J. Med. Microbiol. 63, 293-308.
75. Dickson, R. P., Martinez, F. J., Huffnagle, G. B. (2014) The role of the microbiome in exacerbations of chronic lung diseases. Lancet 384, 691-702.
76. Molyneaux, P. L., Mallia, P., Cox, M. J., Footitt, J., Willis-Owen, S. A., Homola, D., Trujillo-Torralbo, M. B., Elkin, S., Kon, O. M., Cookson, W. O., Moffatt, M. F., Johnston, S. L. (2013) Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 188, 1224-1231.
77. Huang, Y. J., Sethi, S., Murphy, T., Nariya, S., Boushey, H. A., Lynch, S. V. (2014) Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J. Clin. Microbiol. 52, 2813-2823.
78. Millares, L., Ferrari, R., Gallego, M., Garcia-Nunez, M., Perez-Brocal, V., Espasa, M., Pomares, X., Monton, C., Moya, A., Monso, E. (2014) Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1101-1111.
79. Ingenito, E. P., Solway, J., McFadden, E. R., Jr., Pichurko, B., Bowman, H. F., Michaels, D., Drazen, J. M. (1987) Indirect assessment of mucosal surface temperatures in the airways: theory and tests. J. Appl. Physiol. 63, 2075-2083.
80. Williams, H. D., Zlosnik, J. E., Ryall, B. (2007) Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa. Adv. Microb. Physiol. 52, 1-71.